Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women
Information source: Cornell University
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Anemia; Low Birth Weight; Neonatal Mortality
Intervention: multivitamin, mebendazole (Drug)
Phase: Phase 3
Status: Active, not recruiting
Sponsored by: Cornell University Official(s) and/or principal investigator(s): Rebecca J Stoltzfus, PhD, Principal Investigator, Affiliation: Cornell University James M Tielsch, PhD, Principal Investigator, Affiliation: The Johns Hopkins Bloomberg School of Public Health
Summary
The purpose of this research is to compare the efficacy of two low-cost low intervention
packages to prevent and treat severe anemia in pregnant women in Zanzibar, Tanzania. The two
packages are Standard of Care as described by the WHO (presumptive treatment for malaria and
helminths plus daily iron + folic acid supplements) and Enhanced Care (Standard of Care plus
daily multivitamins and a 2nd dose of anthelminthic.)
Clinical Details
Official title: Preventing Unnecessary Blood Transfusions in Pregnant Women in Africa Through Effective Primary Health Care
Study design: Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study
Primary outcome: Incidence of severe anemia (Hb < 7 g/dL)Cure of severe anemia
Secondary outcome: Infant birth weightNeonatal mortality Neonatal morbidity Blood loss during delivery
Detailed description:
This is a clinic-randomized trial involving 8 antenatal clinics and approximately 2500 women.
The specific aims are:
Aim 1: To evaluate the efficacy of the current internationally recommended standard of care,
as described by the WHO, for the prevention of severe anemia among pregnant Zanzibari women.
This aim will be achieved through a pre-post intervention comparison.
Aim 2: To evaluate the efficacy of an enhanced treatment regimen in comparison to the
current standard of care to prevent severe anemia among pregnant Zanzibari women.
Aim 3: To evaluate the efficacy of the current internationally recommended standard of care,
as described by the WHO, for the cure of severe anemia among pregnant Zanzibari women.
Aim 4: To evaluate the efficacy of an enhanced treatment regimen in comparison to the current
standard of care to cure severe anemia among pregnant Zanzibari women.
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Pregnant woman
Exclusion Criteria:
- Not a permanent resident of the community
Locations and Contacts
Public Health Laboratory "Ivo de Carneri", Wawi, Zanzibar, Tanzania
Additional Information
Starting date: April 2004
Last updated: November 16, 2005
|